A61P 13/10
Drugs for disorders of the urinary system: of the bladder
Official title: of the bladder
A61P13/10 (Drugs for disorders of the urinary system: of the bladder) appears on 3,526 US grants and 5,596 published applications in this corpus.
Search patents in A61P- Granted patents
- 3,526
- Published applications
- 5,596
- Assignees
- 1,538
- Inventors
- 9,492
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 7 | 0 |
| 1999 | 12 | 0 |
| 2000 | 16 | 0 |
| 2001 | 37 | 14 |
| 2002 | 41 | 73 |
| 2003 | 59 | 120 |
| 2004 | 38 | 217 |
| 2005 | 62 | 232 |
| 2006 | 93 | 283 |
| 2007 | 90 | 273 |
| 2008 | 123 | 307 |
| 2009 | 171 | 384 |
| 2010 | 209 | 467 |
| 2011 | 233 | 356 |
| 2012 | 245 | 371 |
| 2013 | 291 | 280 |
| 2014 | 282 | 299 |
| 2015 | 240 | 249 |
| 2016 | 188 | 261 |
| 2017 | 202 | 259 |
| 2018 | 170 | 241 |
| 2019 | 174 | 194 |
| 2020 | 156 | 177 |
| 2021 | 97 | 131 |
| 2022 | 82 | 109 |
| 2023 | 54 | 99 |
| 2024 | 58 | 83 |
| 2025 | 53 | 74 |
| 2026 | 33 | 43 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition containing a yeast for preventing simple and/or recurring cystitis6 Oct 2026US 12,751,984 B2Lesaffre Et Compagnie
- Oligodendrocyte progenitor cell compositions25 Aug 2026US 12,716,054 B2Asterias Biotherapeutics, Inc.
- Cyclopentenyl purine derivative or salt thereof18 Aug 2026US 12,709,629 B2FUJIFILM Corporation
- Anticancer combination therapy with N-(1-acryloyl-azetidin-3-yl)-2-((1H-indazol-3-yl)amino)methyl)-1H-imidazole-5-carboxamide inhibitor of KRAS-G12C11 Aug 2026US 12,702,658 B2Astex Therapeutics Limited
- Recombinant BCG, preparation method therefor and application thereof9 Jun 2026US 12,648,989 B2Xuzhou Hairun Biotechnology Co., Ltd.
- Substituted pyrimidinone and azapyrimidinone compounds, compositions, and uses thereof1 Oct 2026US 2026/0297118 A1
- Hunner-type interstitial cystitis therapeutic agent containing dna oligonucleotide that selectively binds to ifn-y24 Sep 2026US 2026/0286367 A1
- Method of treating lower tract urothelial cancer27 Aug 2026US 2026/0248717 A1TARIS Biomedical LLC
- Urination disorder-alleviating agent27 Aug 2026US 2026/0248769 A1Zeria Pharmaceutical Co., Ltd.
- Sulfated Glycosaminoglycan Biomaterials as Proteoglycan Mimics20 Aug 2026US 2026/0240897 A1Glycologix, Inc.
Most cited
By later US patents
- Inhibitors of bruton's tyrosine kinase306US 7,514,444 B2Pharmacyclics, Inc. · 2009
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006
- Methods for using tetanus toxin for beneficial purposes in animals (mammals)171US 7,494,661 B22009
- Inhibitors of brutons tyrosine kinase159US 8,088,781 B2Pharmacyclics, Inc. · 2012
- Bupropion metabolites and methods of use151US 6,342,496 B12002